Christopher, I'm not surprised, seems like all Clinton Foundation donors want to take over everything. Reading up on Mylan, in 2015, they had 85% market share of Epipens in the U.S., soon to be 95%. The CEO is a Senator's daughter.  Another interesting donor is HSBC.